155 related articles for article (PubMed ID: 23427176)
1. Young Australian adults with NF1 have poor access to health care, high complication rates, and limited disease knowledge.
Oates EC; Payne JM; Foster SL; Clarke NF; North KN
Am J Med Genet A; 2013 Apr; 161A(4):659-66. PubMed ID: 23427176
[TBL] [Abstract][Full Text] [Related]
2. Uptake of health monitoring and disease self-management in Australian adults with neurofibromatosis type 1: strategies to improve care.
Crawford HA; Barton B; Wilson MJ; Berman Y; McKelvey-Martin VJ; Morrison PJ; North KN
Clin Genet; 2016 Mar; 89(3):385-91. PubMed ID: 26081173
[TBL] [Abstract][Full Text] [Related]
3. Histologically benign, clinically aggressive: Progressive non-optic pathway pilocytic astrocytomas in adults with NF1.
Strowd RE; Rodriguez FJ; McLendon RE; Vredenburgh JJ; Chance AB; Jallo G; Olivi A; Ahn ES; Blakeley JO
Am J Med Genet A; 2016 Jun; 170(6):1455-61. PubMed ID: 26992069
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Neurofibromatosis Type 1 on the Health and Wellbeing of Australian Adults.
Crawford HA; Barton B; Wilson MJ; Berman Y; McKelvey-Martin VJ; Morrison PJ; North KN
J Genet Couns; 2015 Dec; 24(6):931-44. PubMed ID: 25894096
[TBL] [Abstract][Full Text] [Related]
5. Worries and needs of adults and parents of adults with neurofibromatosis type 1.
Rietman AB; van Helden H; Both PH; Taal W; Legerstee JS; van Staa A; Moll HA; Oostenbrink R; van Eeghen AM
Am J Med Genet A; 2018 May; 176(5):1150-1160. PubMed ID: 29681082
[TBL] [Abstract][Full Text] [Related]
6. Characterization of health concerns in people with neurofibromatosis type 1.
Fleming J; Morgan O; Wong C; Schlub TE; Berman Y
Mol Genet Genomic Med; 2023 Jan; 11(1):e2077. PubMed ID: 36444392
[TBL] [Abstract][Full Text] [Related]
7. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.
Hyman SL; Gill DS; Shores EA; Steinberg A; Joy P; Gibikote SV; North KN
Neurology; 2003 Apr; 60(7):1139-45. PubMed ID: 12682321
[TBL] [Abstract][Full Text] [Related]
8. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic].
Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J
Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360
[TBL] [Abstract][Full Text] [Related]
9. Neurovascular complications in adults with Neurofibromatosis type 1: A national referral center experience.
Sheerin UM; Holmes P; ; Childs L; Roy A; Ferner RE
Am J Med Genet A; 2022 Oct; 188(10):3009-3015. PubMed ID: 36097643
[TBL] [Abstract][Full Text] [Related]
10. [Children with neurofibroma type 1 treated in the Children's Memorial Health Institute].
Perek-Polnik M; Filipek I; Dembowska-Bagińska B; Owsik A; Drogosiewicz M; Jurkiewicz E; Perek D
Med Wieku Rozwoj; 2006; 10(3 Pt 1):699-709. PubMed ID: 17317901
[TBL] [Abstract][Full Text] [Related]
11. Social functioning in adults with neurofibromatosis type 1.
Pride NA; Crawford H; Payne JM; North KN
Res Dev Disabil; 2013 Oct; 34(10):3393-9. PubMed ID: 23911645
[TBL] [Abstract][Full Text] [Related]
12. The range of multiple sclerosis associated with neurofibromatosis type 1.
Perini P; Gallo P
J Neurol Neurosurg Psychiatry; 2001 Nov; 71(5):679-81. PubMed ID: 11606684
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis Clinic: A Report on Patient Demographics and Evaluation of the Clinic.
Mansouri A; Ghadakzadeh S; Maqbool T; Barnett C; Au K; Kongkham P; Bril V; Gelareh Z
Can J Neurol Sci; 2017 Sep; 44(5):577-588. PubMed ID: 27821212
[TBL] [Abstract][Full Text] [Related]
15. Neurological complications of neurofibromatosis type 1 in adulthood.
Créange A; Zeller J; Rostaing-Rigattieri S; Brugières P; Degos JD; Revuz J; Wolkenstein P
Brain; 1999 Mar; 122 ( Pt 3)():473-81. PubMed ID: 10094256
[TBL] [Abstract][Full Text] [Related]
16. A prospective 10 year follow up study of patients with neurofibromatosis type 1.
Cnossen MH; de Goede-Bolder A; van den Broek KM; Waasdorp CM; Oranje AP; Stroink H; Simonsz HJ; van den Ouweland AM; Halley DJ; Niermeijer MF
Arch Dis Child; 1998 May; 78(5):408-12. PubMed ID: 9659085
[TBL] [Abstract][Full Text] [Related]
17. Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis Type 1.
Kongkriangkai AM; King C; Martin LJ; Wakefield E; Prada CE; Kelly-Mancuso G; Schorry EK
Am J Med Genet A; 2019 Apr; 179(4):602-607. PubMed ID: 30737893
[TBL] [Abstract][Full Text] [Related]
18. Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion.
Marque M; Roubertie A; Jaussent A; Carneiro M; Meunier L; Guillot B; Pinson L; Pinson S; Bessis D
J Am Acad Dermatol; 2013 Nov; 69(5):768-775. PubMed ID: 23972508
[TBL] [Abstract][Full Text] [Related]
19. Association between benign and malignant peripheral nerve sheath tumors in NF1.
Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
[TBL] [Abstract][Full Text] [Related]
20. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects.
Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T
Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
